Brief: Egetis Granted Rolling NDA Review By FDA For Emcitate®

Egetis Therapeutics AB (publ)

23/10/2025 07:12

Oct 23 (Reuters) - Egetis Therapeutics AB (publ) EGTX.ST:

EGETIS GRANTED A ROLLING NDA REVIEW BY FDA FOR EMCITATE® (TIRATRICOL) BASED ON CURRENTLY AVAILABLE CLINICAL DATA

Source text: ID:nMFN4CVMd1

Further company coverage: EGTX.ST

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))